Inhaled Loop Diuretics for Congestive Heart Failure

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$199,709.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43HL076041-01A1
Agency Tracking Number:
HL076041
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
ALEXZA MOLECULAR DELIVERY CORPORATION
ALEXZA MOLECULAR DELIVERY CORPORATION, 1001 E MEADOW CIR, PALO ALTO, CA, 94303
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
DANIEL Myers
(650) 687-3912
DMYERS@ALEXZA.COM
Business Contact:
(650) 687-3902
TKING@ALEXZA.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a complex syndrome characterized by multiple symptoms including fluid retention and shortness of breath (dyspnea). Although these symptoms are currently generally treated by oral loop

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government